Olanzapine modulates the default-mode network homogeneity in recurrent drug-free schizophrenia at rest

Aust N Z J Psychiatry. 2017 Oct;51(10):1000-1009. doi: 10.1177/0004867417714952. Epub 2017 Jun 12.

Abstract

Background: Previous studies on brain function alterations associated with antipsychotic treatment for schizophrenia have produced conflicting results because they used short treatment periods and different designs.

Methods: Resting-state functional magnetic resonance imaging scans were obtained from 17 drug-free patients with recurrent schizophrenia and 24 healthy controls. The patients were treated with olanzapine for 6 months and were scanned at three time points (baseline, 6 weeks of treatment and 6 months of treatment). Network homogeneity was used to analyze the imaging data to examine default-mode network homogeneity alterations associated with antipsychotic treatment.

Results: Compared with the controls, the patients at baseline showed increased network homogeneity in the bilateral precuneus and decreased network homogeneity in the bilateral middle temporal gyrus. Network homogeneity values in the bilateral precuneus decreased, and network homogeneity values in the left superior medial prefrontal cortex and the right middle temporal gyrus increased in patients administered olanzapine as antipsychotic treatment. By contrast, network homogeneity values in the left middle temporal gyrus remained unchanged in patients after treatment.

Conclusion: This study provides evidence that antipsychotic treatment with olanzapine modulates the default-mode network homogeneity in schizophrenia. These findings contribute to the understanding of antipsychotic treatment effects on brain functions.

Keywords: Schizophrenia; default-mode network; functional magnetic resonance imaging; network homogeneity; olanzapine.

MeSH terms

  • Adult
  • Antipsychotic Agents / pharmacology*
  • Benzodiazepines / pharmacology*
  • Brain Mapping / methods*
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / physiopathology
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Nerve Net / diagnostic imaging
  • Nerve Net / drug effects*
  • Nerve Net / physiopathology
  • Olanzapine
  • Schizophrenia / diagnostic imaging
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Olanzapine